Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane
NCT ID: NCT04911842
Last Updated: 2023-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
205 participants
OBSERVATIONAL
2021-05-20
2022-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Strategy to Encourage Early Removal of Central Venous Catheters
NCT04136561
Midlines and Thrombophlebitis
NCT03725293
A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line
NCT04656548
Assessing Safety and Performance of the Novel CytaCoat Foley Catheter
NCT07070921
Maintaining Patency in Implanted Port Catheters
NCT02354118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TPU
Thermoplastic polyurethane
TPU
Thermoplastic polyurethane
HBM
Hydrophilic BioMaterial
HydroMID
Hydrophilic biomaterial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HydroMID
Hydrophilic biomaterial
TPU
Thermoplastic polyurethane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have been inserted with a competitor 4 Fr single lumen by the vascular access team
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Access Vascular Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joseph Bunch
Romeoville, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLIN 21-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.